19 . June , 2018 - Tuesday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Lepirudin

Big Image Pronouncation: (LEP-ih-ruh-din)
Class: Thrombin inhibitor

Trade Names:
Refludan
- Powder for Injection 50 mg

Mechanism of Action

Pharmacology

One molecule of lepirudin (rDNA) binds to 1 molecule of thrombin and blocks the thrombogenic activity of thrombin.

Pharmacokinetics

Distribution

Following IV administration, distribution is confined to extracellular fluids and is characterized by an initial t ½ of approximately 10 min.

Metabolism

Lepirudin is thought to be metabolized by release of amino acids via catabolic hydrolysis.

Elimination

Elimination follows first order kinetics and is characterized by a terminal t ½ of approximately 1.3 h. About 48% of the administered dose is excreted in the urine (35% unchanged).

Special Populations

Renal Function Impairment

In patients with marked renal insufficiency (CrCl less than 15 mL/min) and on hemodialysis, the elimination t ½ is prolonged up to 2 days.

Elderly

Systemic Cl is 20% lower in elderly than in younger patients.

Gender

Systemic Cl is about 25% lower in women than men.

Indications and Usage

Anticoagulation in patients with heparin-induced thrombocytopenia and associated thromboembolic disease to prevent further thromboembolic complications.

Unlabeled Uses

Adjunct therapy for treatment of unstable angina; acute MI without ST elevation; prevention of deep vein thrombosis; patients undergoing percutaneous coronary intervention.

Contraindications

Hypersensitivity to hirudins or any component of the product.

Dosage and Administration

Heparin-Induced Thrombocytopenia
Adults

IV 0.4 mg/kg (up to 110 kg body weight) slowly (eg, over 15 to 20 sec) as a bolus followed by 0.15 mg/kg (up to 110 kg/h of body weight) as a continuous IV infusion for 2 to 10 days or longer if clinically needed.

Dose Modification
Adults

IV If the confirmed APTT ratio is below the target range, increase the infusion rate in steps of 20% and determine the APTT ratio again 4 h later. Do not exceed an infusion rate of 0.21 mg/kg/h without checking for coagulation abnormalities that might prevent an appropriate APTT response. If the confirmed APTT ratio is above the target range, stop the infusion for 2 h. At restart, decrease the infusion 50% and determine the APTT ratio again 4 h later.

Renal Function Impairment
Adults

IV Reduce the dose if there is known or suspected renal function impairment (CrCl less than 60 mL/min or serum creatinine above 1.5 mg/dL). In addition to monitoring renal status, APTT monitoring should be used. In all patients with renal function impairment, the bolus dose is to be reduced to 0.2 mg/kg. Reduce the standard initial infusion rate as follows— CrCl 45 to 60 mL/min or serum creatinine 1.6 to 2 mg/dL— Administer at 50% of the standard infusion rate (0.075 mg/kg/h). CrCl 30 to 44 mL/min or serum creatinine 2.1 to 3 mg/dL— Administer at 30% of the standard infusion rate (0.045 mg/kg/h). CrCl 15 to 29 mL/min or serum creatine 3.1 to 6 mg/dL— Administer at 15% of the standard infusion rate (0.0225 mg/kg/h). Less than 15 mL/min or serum creatine greater than 6 mg/dL— Avoid or stop infusion.

Concomitant Use of Thrombolytic Therapy
Adults

IV Initial bolus of 0.2 mg/kg followed by continuous infusion of 0.1 mg/kg/h.

Switching to Oral Anticoagulants
Adults

Gradually reduce the lepirudin dose to reach an APTT ratio just above 1.5 before initiating oral anticoagulation. Initiate coumarin derivatives only when platelet counts are normalizing. Start maintenance dose with no loading dose. To avoid prothrombotic effects when initiating coumarin, continue parenteral anticoagulation for 4 to 5 days.

General Advice

  • For IV administer only. Not for intradermal, IM, or subcutaneous administration.
  • Follow manufacturer's instructions for reconstitution of powder and dilution of reconstituted solution.
  • Use reconstituted solution immediately. Discard any unused infusion solution after 24 h.
  • Refer to manufacturer's insert for compatibility with IV fluids and other medications.
  • Do not administer if solution is cloudy, discolored, or contains particulate matter.
  • Warm solution to room temperature before administration.
  • Ensure that baseline hematocrit or hemoglobin, platelet count, and APTT ratio (patient APTT over APTT reference value) are performed and evaluated prior to starting therapy.
  • Do not initiate therapy if baseline APTT ratio is 2.5 or more.
  • Ensure that APTT ratio is determined 4 h after start of therapy and after every dosage adjustment, and at least every 24 h thereafter during therapy.
  • Ensure that dosage is adjusted to maintain APTT ratio between 1.5 and 2.5 following manufacturer's recommendations for dosage adjustments.

Storage/Stability

Store unopened vials in refrigerator (36° to 46°F) or at controlled room temperature (59° to 77°F). Reconstituted solution remains stable for up to 24 h at room temperature (eg, during infusion).

Drug Interactions

Coumarin derivatives (eg, vitamin K antagonists), thrombolytics (eg, alteplase, streptokinase)

Risk of bleeding may be increased.

Laboratory Test Interactions

None well documented.

Adverse Reactions

Cardiovascular

Heart failure (2%).

Dermatologic

Bleeding from puncture sites and wounds (11%); allergic skin reactions (4%).

EENT

Epistaxis (4%).

GI

GI and rectal bleeding (5%).

Genitourinary

Hematuria (4%); vaginal bleeding (2%).

Hematologic

Anemia or isolated drop in hemoglobin (12%); sepsis (4%).

Hepatic

Abnormal liver function (5%).

Renal

Abnormal renal function (2%).

Respiratory

Pneumonia (4%).

Miscellaneous

Hematoma or unclassified bleeding (11%); fever, multiorgan failure (4%); unspecified infections (2%); intracranial bleeding; allergic reactions (including cough, bronchospasm, stridor, dyspnea [1% to less than 10%]); anaphylactic reactions (postmarketing).

Precautions

Pregnancy

Category B .

Lactation

Undetermined.

Children

Safety and efficacy not established.

Hypersensitivity

Allergic and hypersensitivity reactions, including anaphylaxis (resulting in shock or death), can occur.

Renal Function

Adjust the dose as indicated.

Hepatic Function

May enhance the anticoagulant effect.

Hemorrhagic events

Hemorrhagic events may occur at any site. Monitor patient for signs of bleeding throughout therapy. If bleeding develops (eg, epistaxis; hematuria; hematemesis; bloody or black, tarry stools) or is suspected (eg, unexplained fall in hematocrit or BP or any unexplained symptoms), notify health care provider immediately.

Intracranial bleeding

Life-threatening intracranial bleeding may occur with coadministration of thrombolytic therapy (eg, alteplase, streptokinase).

Overdosage

Symptoms

Bleeding.

Patient Information

  • Advise patient, family, or caregiver that medication will be prepared and administered by a health care professional in a hospital setting.
  • Instruct patient, family member, or caregiver to report any signs of bleeding or allergic reaction immediately.

Recent Drug Updates at DrugIndexOnline:





Alumina and Sodium Bicarbonate Alumina and Sodium Bicarbonate
Some commonly used brand names are: In the U.S.— Advanced Formula Di-Gel 29 Alamag 2 Alamag Plus 9 Alenic Alka 15 Alenic Alka Extra Strength 18 Alka-Mints 27 Alkets 27 Alkets Extra Strength 27 Almacone 9 Almacone II 9 AlternaGEL 21 Alu-Cap 25 Aludrox 9 Alu-Tab 25 Amitone 27 Amphojel 25 An more...

Aminophylline (Theophylline Ethylenediamine) Aminophylline (Theophylline Ethylenediamine)
( Theophylline Ethylenediamine ) Pronouncation: (am-in-AHF-ih-lin) Class: Xanthine derivative Trade Names: Aminophylline - Injection 250 mg (equiv. to 197 mg theophylline) per 10 mL Trade Names: Aminophylline - Liquid, oral 105 mg (equiv. to 90 mg theophylline) per 5 mL Trade Names: Phyllocontin - more...

aspirin and hydrocodone aspirin and hydrocodone
Generic Name: aspirin and hydrocodone (AS pir in/hye droe KOE done) Brand Names: Alor 5/500, Azdone, Damason-P, Lortab ASA, Panasal 5/500 What is aspirin and hydrocodone? Hydrocodone (related to codeine) is in a class of drugs called narcotic analgesics. It is a pain reliever. Aspirin is more...

Dynabac Dynabac
Generic Name: dirithromycin (dir ith roe MYE sin) Brand Names: Dynabac What is Dynabac (dirithromycin)? Dirithromycin is in a class of drugs called macrolide antibiotics. Dirithromycin fights bacteria in your body. Dirithromycin is used to treat many different types of bacterial infecti more...

Etoposide Etoposide
Some commonly used brand names are: In the U.S.— VePesid Etopophos Toposar In Canada— VePesid Generic name product may be available in the U.S. and Canada. Another commonly used name is VP-16 . Category Antineoplastic Description Etoposide (e-toe-POE-side)belongs to the g more...

Hepsera Hepsera
Generic Name: Adefovir (ah-DEF-oh-veer) Brand Name: HepseraSevere worsening of hepatitis (rarely including death) has occurred when Hepsera has been stopped. If you are instructed to stop taking Hepsera , your doctor will monitor you closely for signs of worsening hepatitis. Be sure to keep all more...

mebendazole mebendazole
Generic Name: mebendazole (me BEN da zole) Brand Names: Vermox What is mebendazole? Mebendazole is an "antihelmintic," or anti-worm, medication. It prevents worms from growing or multiplying in your body. Mebendazole is used to treat infections caused by worms such as whipworm, pinworm, more...

Muse Muse
Generic name: Alprostadil Brand names: Edex, Muse, Caverject Why is Muse prescribed? Caverject is used to treat male impotence. Your doctor also may use Caverject to help diagnose the exact nature of your impotence. Caverject and the similar brand Edex are both taken by injection. A third brand, more...